John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 2,098 shares at $13.39 ($28K) on 2025-08-12, disclosed to the SEC on 2025-08-14.
Open-market sale of $28k EWTX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |
| EWTX | SELL | 2024-02-09 | $834K | — | Filing → |